Immuneering Corporation (IMRX)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 43.89M |
| Enterprise value | -23.01M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 563.62 |
| Price/book (mrq) | 0.56 |
| Enterprise value/revenue | 191.91k |
| Enterprise value/EBITDA | -1.53 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.60 |
| 52-week change 3 | -86.89% |
| S&P500 52-week change 3 | 25.22% |
| 52-week high 3 | 11.8100 |
| 52-week low 3 | 1.3000 |
| 50-day moving average 3 | 1.5882 |
| 200-day moving average 3 | 5.0732 |
Share statistics
| Avg vol (3-month) 3 | 408.46k |
| Avg vol (10-day) 3 | 278.34k |
| Shares outstanding 5 | 29.65M |
| Implied shares outstanding 6 | 29.65M |
| Float 8 | 17.41M |
| % held by insiders 1 | 29.15% |
| % held by institutions 1 | 34.88% |
| Shares short (15 May 2024) 4 | 3.53M |
| Short ratio (15 May 2024) 4 | 9.2 |
| Short % of float (15 May 2024) 4 | 15.98% |
| Short % of shares outstanding (15 May 2024) 4 | 11.89% |
| Shares short (prior month 15 Apr 2024) 4 | 2.73M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -37.73% |
| Return on equity (ttm) | -61.38% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -58.69M |
| Net income avi to common (ttm) | -54.18M |
| Diluted EPS (ttm) | -1.8600 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 71.28M |
| Total cash per share (mrq) | 2.4 |
| Total debt (mrq) | 4.38M |
| Total debt/equity (mrq) | 5.56% |
| Current ratio (mrq) | 14.38 |
| Book value per share (mrq) | 2.65 |
Cash flow statement
| Operating cash flow (ttm) | -50.04M |
| Levered free cash flow (ttm) | -31.72M |
© 2024 Yahoo. All rights reserved.